Stifel Nicolaus Trims Vor Biopharma (NYSE:VOR) Target Price to $15.00

Vor Biopharma (NYSE:VOR – Free Report) had its price objective trimmed by Stifel Nicolaus from $16.00 to $15.00 in a research report sent to investors on Friday, FlyOnTheWall reports. Other analysts have also issued research reports about the company. HC Wainwright reiterated a buy rating and set a $17.50 target price on shares of Vor […]

Related Keywords

Chicago ,Illinois ,United States ,Stifel Nicolaus ,Denali Advisors ,Artal Group ,Capital Management ,Vor Biopharma Inc ,Chicago Partners Investment Group ,Vor Biopharma Company Profile ,Bourgeon Capital Management ,Vor Biopharma ,Free Report ,Get Free Report ,Partners Investment Group ,Biopharma Inc ,Vor Biopharma Daily ,Nyse Vor ,Kvor ,Medical ,Lower Price Target ,